Restless legs syndrome. Other specified extrapyramidal and movement disorders
Conditions
Interventions
treatment with vitamin C tablets plus ferrous sulfate tablets with initial dose of vitamin C (250 mg) plus a ferrous sulfate (60 mg) daily in the first month
two tablets of vitamin C (500 mg) plus two Ferrous sulfate tablets (120 mg) in the second month and 3 tablets of vitamin C (750 mg) plus three tablets of Ferrous sulfate (180 mg) in the third month wi
treatment will be done only one Ferrous sulfate tablet (60 mg) in the first month
two tablets of Ferrous sulfate (120 mg) in the second month and three tablets of Ferrous sulfate (180 mg) in the third month.
Sponsors
Vice chancellor for research; Shahroud University medical and Sciences
Eligibility
Sex/Gender
All
Age
15 Years to 70 Years
Inclusion criteria
Inclusion criteria: Patients under regular hemodialysis Age over 15 and under 70 years of patients Definitive diagnosis of restless leg syndrome No specific medication associated with restless leg therapy in the last two weeks The absence of underlying disorders of the skeletal system Having of satisfaction in research
Exclusion criteria
Exclusion criteria: Need to kidney transplant before study completion Hyperparathyroidism The presence of any underlying abnormalities of the skeletal system Unstable of vital signs and hemodynamic Dissatisfaction in research
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Severity of Restless Leg Syndroum. Timepoint: Once a Month. Method of measurement: Standard Questioner of Restless Leg syndrome evaluation. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactDr.Mohammad Bagher Sohrabi
Shahroud University of Medical Sciences
Outcome results
None listed